UNION therapeutics A/S: Financial statements 2016
CVR: 33963750
Source: annual report 2016, Danish Business Authority
01/01/2016 – 31/12/2016
UNION therapeutics A/S (CVR 33963750) has filed annual accounts for 2016. In 2016, the company reported revenue of USD 728,695 and a net result of USD -485,441 compared with USD -223,943 the year before. That is an increase of 5.5% compared with the year before. The profit margin was -66.6%. Equity in the 2016 report amounted to USD -194,987.
- Revenue
- USD 728,695
- Gross Profit
- USD -342,686
- Profit/Loss
- USD -485,441
- Equity
- USD -194,987
- Total Assets
- USD 775,508
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | 729K USD | -343K USD | -485K USD | -195K USD | - |
| 2015 | 691K USD | -154K USD | -224K USD | -71K USD | - |
| 2014 | - | 3.1M | 578K | 988K | - |
| 2013 | - | 1.2M | 359K | 410K | - |
Official annual report
Find more companies like UNION therapeutics A/S
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2016
UNION therapeutics A/S has published its annual report for 2015. Revenue came to DKK 690,674, and the net result was DKK -223,943.
As of April 1, 2016, EY Godkendt Revisionspartnerselskab has been appointed auditor of UNION therapeutics A/S.
As of March 17, 2016, RSM PLUS P/S STATSAUTORISEREDE REVISORER has stepped down as auditor of UNION therapeutics A/S.
As of January 26, 2016, Rasmus Vendler Toft-Kehler has joined the board of directors of UNION therapeutics A/S.
As of January 26, 2016, Morten Otto Alexander Sommer has joined the board of directors of UNION therapeutics A/S.
As of January 26, 2016, Astrid Sommer has joined the board of directors of UNION therapeutics A/S.
As of January 26, 2016, Anne Katrine Toft-Kehler has joined the board of directors of UNION therapeutics A/S.
About UNION therapeutics A/S
UNION therapeutics A/S is a Danish company of the type Aktieselskab based in Hellerup, founded in 2011. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named AntibioTx A/S and ANTIBIOTX ApS. The management consists of Kim Domela Kjøller, Morten Otto Alexander Sommer and Rasmus Vendler Toft-Kehler. The board consists of Stig Løkke Pedersen (chair), Andrew John Oakley, Morten Otto Alexander Sommer and Peter Kristensen. The company's owners include MANJIN ApS, VENDLER ApS and T&W HOLDING A/S. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK -11,802,644 and a net result of DKK -32,142,051 compared with DKK -98,922,000 the year before. Equity in the 2025 report amounted to DKK -147,650,138.